Search research articles
Contact Us
Filters
Showing results (341-350 of 359) with videos related to
Page
of 36
Sort By:
JTO Clinical and Research Reports
|
March 17, 2023
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC
Marcelo V Negrao, Vassiliki A Papadimitrakopoulou, Andrew C Price, et al.
Frontiers in Bioscience (Landmark Edition)
|
December 3, 2021
Anti-Parkinson's evaluation of <i>Brassica juncea</i> leaf extract and underlying mechanism of its phytochemicals
Uzma Saleem, Shabana Bibi, Muhammad Ajmal Shah, et al.
Nature Medicine
|
January 9, 2024
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Shubham Pant, Zev A Wainberg, Colin D Weekes, et al.
Frontiers in Oncology
|
May 15, 2024
Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan
Taher Abu Hejleh, Karim AlSawalha, Sufian Abdel Hafiz, et al.
Nature
|
September 21, 2023
Cingulate dynamics track depression recovery with deep brain stimulation
Sankaraleengam Alagapan, Ki Sueng Choi, Stephen Heisig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2025
Safety and Tolerability of Lete-cel in NSCLC-Reply
Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer
Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
Molecules (Basel, Switzerland)
|
February 15, 2022
Bioactive-Based Cosmeceuticals: An Update on Emerging Trends
Anju Goyal, Aditya Sharma, Jasanpreet Kaur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2024
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer
Daniel Morgensztern, Neal Ready, Melissa L Johnson, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin αvβ1 and FAK
Shiela C Samson, Anthony Rojas, Rebecca G Zitnay, et al.
Page
of 36
Search research articles
Search
Showing results (341-350 of 359) with videos related to
Sort By:
Page
of 36
JTO Clinical and Research Reports
|
March 17, 2023
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC
Marcelo V Negrao, Vassiliki A Papadimitrakopoulou, Andrew C Price, et al.
Frontiers in Bioscience (Landmark Edition)
|
December 3, 2021
Anti-Parkinson's evaluation of <i>Brassica juncea</i> leaf extract and underlying mechanism of its phytochemicals
Uzma Saleem, Shabana Bibi, Muhammad Ajmal Shah, et al.
Nature Medicine
|
January 9, 2024
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Shubham Pant, Zev A Wainberg, Colin D Weekes, et al.
Frontiers in Oncology
|
May 15, 2024
Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan
Taher Abu Hejleh, Karim AlSawalha, Sufian Abdel Hafiz, et al.
Nature
|
September 21, 2023
Cingulate dynamics track depression recovery with deep brain stimulation
Sankaraleengam Alagapan, Ki Sueng Choi, Stephen Heisig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2025
Safety and Tolerability of Lete-cel in NSCLC-Reply
Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer
Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
Molecules (Basel, Switzerland)
|
February 15, 2022
Bioactive-Based Cosmeceuticals: An Update on Emerging Trends
Anju Goyal, Aditya Sharma, Jasanpreet Kaur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2024
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer
Daniel Morgensztern, Neal Ready, Melissa L Johnson, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin αvβ1 and FAK
Shiela C Samson, Anthony Rojas, Rebecca G Zitnay, et al.
Page
of 36